Table 1.
Summary of reported UCNP‐MOF heterostructures for PDT
UNCP‐MOF Heterostructures | Architecture | Additional functional materials | Therapeutic modalities | Ref. |
---|---|---|---|---|
(NaFY4:Yb/Er)‐(PCN‐224) | Core‐satellite | – | PDT | [ 46 ] |
(NaGdF4:Yb,Tm@NaGdF4)‐(ZIF‐8) | Polyhedron | g‐C3N4, CDs | PDT | [ 101 ] |
(UiO‐68‐NH2)‐(NaGdF4:Yb, Er@NaGdF4:Nd,Yb) |
Core‐satellite | Ce6, RB | PDT | [ 45 ] |
(NaGdF4:Yb,Er@NaGdF4)‐(PCN‐224) | Dimer | DOX | PDT + chemotherapy | [ 37 ] |
(NaYF4:Yb/Er)@(ZIF‐8) | Core‐shell | MB, catalase | PDT | [ 102 ] |
(MIL‐100(Fe))‐(NaYF4:Yb,Tm) | Core‐satellite | Fe3O4 NPs | PDT + PCT | [ 103 ] |
(NaYF4:Yb/Er@NaYbF4:Nd@NaGdF4)@mSiO2@(ZIF‐90) | Core‐shell | DOX, RB, PEGFA | PDT + chemotherapy | [ 104 ] |
(NaYF4)@(PCN‐224) | Dimer | TiO2 | Type I and Type II PDT | [ 105 ] |
(NaGdF4:Yb,Er@NaGdF4:Yb,Nd@NaGdF4)‐(PCN‐224) | Dimer | TPP | PDT | [ 106 ] |
(NaYF4@NaYbF4:Er@NaYF4)@(PCN‐222) | Core‐shell | AuNPs | PDT + cancer starvation therapy | [ 107 ] |
(NaGdF4:Yb,Er@NaGdF4)@(PCN‐224) | Core‐shell | TPZ, α‐PD‐L1 | PDT + chemotherapy + immunotherapy | [ 40 ] |
(NaYF4:Yb,Tm@NaYF4:Yb@NaNdF4)‐(PCN‐224(Fe)) | Dimer | Biotin | PDT + CDT + SDT | [ 108 ] |
(NaYF4:Yb,Er)‐(PCN‐224) | – | LA | PDT + gas therapy | [ 109 ] |